7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 
      
    		                         
      cash flows from operating activities:
    		                         
      net income
    		-38,348,000 -23,482,000 112,879,000 -10,482,000 -26,430,000 -25,695,000 -26,374,000 -26,958,000 -24,542,000 -30,654,000 -22,545,000 -25,655,000 -26,111,000 -24,652,000 -24,649,000 -24,448,000 -22,597,000 -21,967,000 -16,793,000 -14,561,000 -13,684,000 -12,959,000 -11,039,000 -10,160,000 -8,604,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                         
      depreciation
    		442,000 446,000 477,000 526,000 540,000 548,000 563,000 624,000 637,000 611,000 597,000 609,000 388,000 302,000 247,000 235,000 254,000 249,000 236,000 237,000 234,000 224,000 193,000 139,000 126,000 
      amortization and accretion of marketable securities
    		-615,000 527,000 -494,000 -782,000 -547,000 -289,000 -24,000 -89,000 -122,000 -146,000 32,000 -151,000 -102,000 -193,000 235,000 57,000 49,000         
      stock-based compensation
    		8,039,000 7,598,000 6,753,000 7,139,000 7,494,000 7,427,000 5,410,000 6,058,000 6,552,000 6,760,000 5,887,000 5,790,000 5,926,000 6,163,000 4,975,000 4,686,000 4,614,000 4,452,000 2,698,000 1,580,000 1,785,000 1,649,000 754,000 712,000 731,000 
      impairment of right of use asset
    		                         
      loss on disposal of property and equipment
    		       0        0 0 0 29,000 0 0 0 3,000   
      reduction in the carrying amount of right of use assets
    		547,000 612,000 599,000 582,000 571,000 562,000 550,000 591,000 563,000 556,000 550,000 543,000 536,000 533,000 377,000 386,000 322,000 277,000 271,000 266,000 262,000 257,000 253,000   
      changes in assets and liabilities:
    		                         
      accounts receivable
    		                         
      prepaid expenses and other current assets
    		5,640,000 -3,850,000 -2,555,000 -1,443,000 600,000 -644,000 -349,000 1,353,000 -514,000 1,778,000 -2,088,000 -1,528,000 581,000 -971,000 -3,265,000 -778,000 228,000 -1,223,000 -1,078,000 -2,823,000 -80,000 949,000 -924,000 863,000 -1,866,000 
      accounts payable, accrued liabilities and lease liabilities
    		4,881,000 2,765,000 4,741,000  -749,000 3,577,000 -1,919,000                   
      deferred revenue
    		-4,060,000 -10,038,000 9,427,000 -20,912,000 -3,094,000 -2,963,000 -2,423,000 -1,079,000 -1,854,000 3,722,000 -4,140,000 -2,180,000 -1,928,000 -2,170,000 58,014,000           
      net cash from operating activities
    		-30,366,000 -25,422,000 131,827,000 -23,193,000 -21,615,000 -17,477,000 -24,566,000 -20,649,000 -17,262,000 -21,800,000 -21,356,000 -22,373,000 -22,056,000 -19,928,000 32,491,000 -16,258,000 -14,682,000 -15,831,000 -20,136,000 -10,931,000 -10,873,000 -9,646,000 -10,771,000 -10,201,000 -8,048,000 
      capex
    		-132,000 -154,000 -152,000 -42,000 -103,000 -46,000 -12,000 -229,000 -383,000 -839,000 -165,000 -409,000 -2,030,000 -682,000 -841,000 -203,000 -273,000 -520,000 -204,000 -90,000 -269,000 -81,000 -610,000 -568,000 -583,000 
      free cash flows
    		-30,498,000 -25,576,000 131,675,000 -23,235,000 -21,718,000 -17,523,000 -24,578,000 -20,878,000 -17,645,000 -22,639,000 -21,521,000 -22,782,000 -24,086,000 -20,610,000 31,650,000 -16,461,000 -14,955,000 -16,351,000 -20,340,000 -11,021,000 -11,142,000 -9,727,000 -11,381,000 -10,769,000 -8,631,000 
      cash flows from investing activities:
    		                         
      purchases of marketable securities
    		-23,925,000 -181,553,000 -19,016,000 -29,139,000 -49,901,000       4,870,000 -9,706,000 -52,543,000 -143,941,000 0 -4,991,000         
      purchases of property and equipment
    		-132,000 -154,000 -152,000 -42,000 -103,000 -46,000 -12,000 -229,000 -383,000 -839,000 -165,000 -409,000 -2,030,000 -682,000 -841,000 -203,000 -273,000 -520,000 -204,000 -90,000 -269,000 -81,000 -610,000 -568,000 -583,000 
      sales of marketable securities
    		33,151,000 33,230,000 32,800,000 30,000,000 20,000,000 0 10,000,000 15,000,000 15,000,000 24,312,000 53,250,000 18,029,000 79,000,000 53,371,000 9,000,000           
      net cash from investing activities
    		9,094,000 -148,477,000 13,632,000 819,000 -30,004,000 -88,278,000 9,988,000 14,771,000 14,617,000 23,473,000 53,085,000 22,490,000 67,264,000 146,000 -135,782,000 11,797,000 -5,264,000 -82,755,000 -204,000 -90,000 -269,000 -81,000 -610,000 -569,000 -583,000 
      cash flows from financing activities:
    		                         
      proceeds from employee stock purchase plan
    		632,000 0 370,000 0 364,000 0 168,000 1,000 348,000 53,000 153,000 0 401,000 0 169,000 0 334,000 0 175,000 0      
      proceeds from issuance of common stock upon exercise of stock options
    		2,488,000 554,000 1,004,000 567,000 139,000 766,000 250,000 4,000 214,000 -5,000 158,000 42,000 33,000 326,000 93,000 172,000 73,000 161,000 371,000 1,595,000 681,000 368,000 199,000  19,000 
      proceeds from issuance of common stock in controlled equity offering sales agreements
    		    7,656,000                     
      proceeds from follow-on offering, net of underwriting discounts, commissions and offering costs
    		   0 0                     
      net cash from financing activities
    		3,120,000 554,000 1,374,000 568,000 8,159,000 120,650,000 1,717,000 7,343,000 562,000 48,000 45,054,000 43,000 434,000 3,425,000 42,507,000 171,000 408,000 159,000 546,000 106,868,000 673,000 369,000 198,000 192,000 -1,000,000 
      net decrease in cash, cash equivalents and restricted cash
    		           160,000 45,642,000 -16,357,000 -60,784,000  -19,538,000      -11,183,000   
      cash, cash equivalents and restricted cash—beginning of period
    		-1,000 0 128,780,000  0 0 192,011,000  0 0 114,125,000  0 0 145,464,000  0 0 287,513,000  0 0 222,676,000  0 
      cash, cash equivalents and restricted cash—end of period
    		-18,153,000 -173,345,000 275,613,000  -43,460,000 14,895,000 179,150,000  -2,083,000 1,721,000 190,908,000  45,642,000 -16,357,000 84,680,000  -19,538,000 -98,427,000 267,719,000  -10,469,000 -9,358,000 211,493,000  -9,631,000 
      supplemental disclosure of non-cash investing and financing activities:
    		                         
      property and equipment included in accrued expense and accounts payable
    		41,000 24,000 27,000 50,000   6,000    545,000 -285,000 -348,000 453,000 301,000 1,229,000   97,000 -70,000 36,000 5,000 35,000   
      net increase in cash, cash equivalents and restricted cash
    		 -173,345,000 146,833,000 -21,806,000 -43,460,000 14,895,000 -12,861,000 1,465,000 -2,083,000 1,721,000 76,783,000        -19,794,000 95,847,000 -10,469,000   -10,578,000 -9,631,000 
      deferred offering costs not yet paid
    		      402,000             145,000 -60,000     
      accounts payable, accrued liabilities, and operating leases
    		                         
      proceeds from controlled equity offering sales agreement, net of commissions
    		                         
      cash, cash equivalents and restricted cash—beginning of year
    		                         
      cash, cash equivalents and restricted cash—end of year
    		                         
      right-of-use assets recognized in exchange for operating leases
    		           0 0             
      proceeds from controlled equity offering sales agreements
    		      1,299,000   0 44,743,000  0             
      proceeds from controlled equity offering sales agreement
    		       7,338,000       42,245,000           
      other
    		                         
      accounts payable and accrued liabilities
    		        2,017,000 -4,427,000 351,000 199,000 -1,346,000 1,060,000 -3,443,000 3,604,000 2,448,000 2,344,000 -5,499,000 4,370,000 610,000 234,000 -11,000 -1,761,000 1,557,000 
      proceeds from issuance of common stock upon public offerings
    		                         
      payment of offering costs
    		                         
      deferred financing costs
    		                   181,000      
      right-of-use assets recognized in exchange for operating leases under topic 842
    		                         
      payments of follow-on offering costs
    		                1,000         
      right of use asset recognized in exchange for operating lease
    		                         
      right-of-use assets recognized in exchange for operating leases upon adoption of topic 842
    		                   0 0 0 2,153,000   
      right-of-use asset recognized upon entering into amended lease
    		                         
      payments on capital lease
    		                      -1,000   
      deferred rent
    		                       6,000 8,000 
      proceeds from sale of property and equipment
    		                       -1,000 0 
      proceeds from the issuance of common stock upon initial public offering
    		                        0 
      payments of initial public offering costs
    		                       0 -1,020,000 
      proceeds from issuance of convertible preferred stock
    		                         
      preferred stock issuance cost
    		                         
      proceeds from issuance of common stock upon initial public offering
    		                         
      proceeds from exercise of stock options
    		                         
      property and equipment included in accrued expenses and accounts payable
    		                         
      issuance of convertible preferred stock in exchange for simple agreement for future equity
    		                         
      gain/loss on disposal of property and equipment
    		                        0 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.